Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Group (TSE:CRON)
TSX:CRON
Holding TSE:CRON?
Track your performance easily
CRON Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$2.56 - C$4.28
Previous CloseN/A
Volume78.08K
Average Volume (3M)130.51K
Market Cap
$1.08B
Enterprise ValueC$59.24M
Total Cash (Recent Filing)$2.58M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Mar 04, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding382,294,700
10 Day Avg. Volume129,335
30 Day Avg. Volume130,514
Standard Deviation0.15
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.75
Price to Cash Flow (P/CF)15.60
P/FCF Ratio34.10
Enterprise Value/Market Cap0.05
Enterprise Value/Revenue0.54
Enterprise Value/Gross Profit4.97
Enterprise Value/Ebitda-1.30
Forecast
1Y Price Target
C$2.98Price Target Upside5.19% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Cronos Group News
PremiumCompany Announcements
Cronos Group Sees Revenue Surge and Market Dominance
Bulls Say, Bears Say
Bulls Say
Cost ManagementOperating expenses decreased by 8% year-over-year, driven by effective sales and cost controls, enhancing overall financial efficiency.
Financial PerformanceCRON's 2Q24 net sales were $27.8 million, a 46% increase year-over-year and a quarterly high, reflecting strong financial performance.
Sales GrowthCronos Group is showing progress in sales growth and cost reduction, which indicates some improvement in the company's financial health.
Bears Say
Profitability UncertaintyThe timing of profitability, disruptions due to the Israel-Hamas war, changes to US federal laws and Canadian reform to the Cannabis Act are unclear.
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
Valuation ConcernsCronos Group's enterprise value is slightly negative, attributed to the lack of US reform and investor restrictions, which pressures the stock compared to its peers.
---
Options Prices
Currently, No data available
---
Ownership Overview
3.41% Insiders
1.80% Mutual Funds
― Other Institutional Investors
90.43% Public Companies and Individual Investors
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was C$2.56 and its highest was C$4.28 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is $1.08B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Mar 04, 2025 which is in 51 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Nov 12, 2024. The company reported C$0.029 earnings per share for the quarter, beating the consensus estimate of C$0.007 by C$0.022.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is 0.
How many shares outstanding does Cronos Group have?
Cronos Group has 382,294,700 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of C$0.029 in its last earnings report, beating expectations of C$0.007. Following the earnings report the stock price went up 16.236%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in TSE:CRON
---
Cronos Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
C$2.98 (5.19% Upside)
C$2.98 (5.19% Upside)
Blogger Sentiment
Bullish
TSE:CRON Sentiment 84%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.3%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.94%
12-Months-Change
Fundamentals
Return on Equity
-4.32%
Trailing 12-Months
Asset Growth
2.96%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
---
CRON Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
Cronos demonstrated significant revenue growth and market leadership in Canada and international markets, with strong financial performance. However, challenges such as flower supply shortages and geopolitical issues in Israel were noted. The overall sentiment of the call is positive, given the significant achievements outweighing the challenges.Read More>---
CRON Stock 12 Month Forecast
Average Price Target
C$2.98
▲(5.19% Upside)
Technical Analysis
Cronos Group
―
Aurora Cannabis
―
Tilray
―
Canopy Growth
―
OrganiGram Holdings
―
Corbus Pharmaceuticals Holdings
―
Curaleaf Holdings
―
Best Analysts Covering CRON
1 Year
1 Year Success Rate
12/21 ratings generated profit
1 Year Average Return
+10.68%
reiterated a buy rating 5 months ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +10.68% per trade.
---